FDA Approves Reformulation of Vonoprazan Tablets for Therapeutic Treatment of Helicobacter Pylori
The FDA approved the Prior Approval Supplement (PAS) for reformulation of vonoprazan tablets for vonoprazan tablets, amoxicillin capsules, and clarithromycin tablets (Voquenza Triple Pak; Phathom Pharmaceuticals) as well as vonoprazan tablets and amoxicillin capsules (Voquenza Dual Pak; Phathom Pharmaceuticals) for the treatment of Helicobacter pylori (H. pylori) infection in adult patients. The treatment regimens contain …